Asterias Biotherapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Fremont CA United States (2012)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2012
NCT00510133
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Asterias Biotherapeutics, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

ast-opc1 (1 trial)

grnvac1 (1 trial)

Drugs in Phase 1 Trials (1)

grnopc1 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Spinal Cord Injuries (Phase 2)

Spinal Injuries (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3